Henry M Kuerer Selected Research

Ovarian Neoplasms (Ovarian Cancer)

1/2015	Predictors that Influence Election of Contralateral Prophylactic Mastectomy among Women with Ductal Carcinoma in Situ who are BRCA-Negative.
10/2014	Predictors that influence contralateral prophylactic mastectomy election among women with ductal carcinoma in situ who were evaluated for BRCA genetic testing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Henry M Kuerer Research Topics

Disease

176	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2002
101	Neoplasms (Cancer) 11/2023 - 01/2002
37	Neoplasm Metastasis (Metastasis) 01/2024 - 05/2002
31	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2022 - 10/2003
21	Pathologic Complete Response 11/2023 - 08/2005
9	Necrosis 04/2024 - 05/2004
7	Residual Neoplasm 01/2021 - 04/2004
6	Triple Negative Breast Neoplasms 01/2024 - 01/2017
6	Inflammatory Breast Neoplasms 11/2020 - 07/2007
6	Carcinoma (Carcinomatosis) 03/2016 - 05/2002
4	Lymphedema (Milroy Disease) 01/2023 - 10/2006
4	Disease Progression 10/2021 - 06/2006
3	Postoperative Pain 03/2020 - 09/2009
3	Margins of Excision 12/2019 - 02/2003
3	Lymphatic Metastasis 01/2017 - 06/2010
3	Lobular Carcinoma 09/2012 - 10/2006
3	Unilateral Breast Neoplasms 03/2011 - 01/2005
3	Wounds and Injuries (Trauma) 01/2010 - 02/2002
3	Ductal Carcinoma 10/2007 - 10/2006
2	Pain (Aches) 03/2020 - 11/2009
2	Circulating Neoplastic Cells 01/2020 - 11/2015
2	Ovarian Neoplasms (Ovarian Cancer) 01/2015 - 10/2014
2	Infections 08/2014 - 10/2004
2	Extranodal Extension 01/2012 - 06/2005
2	Seroma 01/2011 - 05/2004
2	Carcinogenesis 01/2009 - 11/2004
2	Congenital Abnormalities (Deformity) 12/2008 - 01/2006
2	Edema (Dropsy) 08/2005 - 07/2002
2	Anaphylaxis (Anaphylactic Shock) 08/2005 - 02/2004
2	Hypotension (Low Blood Pressure) 08/2005 - 08/2004
1	Neoplasm Micrometastasis 01/2018
1	Cellulitis 10/2017
1	Overweight 06/2012
1	Breast Diseases (Breast Disease) 05/2012
1	Lymphadenopathy 04/2011
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 08/2007

Drug/Important Bio-Agent (IBA)

22	Estrogen ReceptorsIBA 03/2017 - 08/2004
13	Hormones (Hormone)IBA 11/2023 - 11/2002
10	Progesterone Receptors (Progesterone Receptor)IBA 03/2017 - 04/2002
8	Proteins (Proteins, Gene)FDA Link 03/2006 - 12/2002
7	Tamoxifen FDA LinkGeneric 11/2021 - 01/2002
7	AnthracyclinesIBA 05/2012 - 06/2002
7	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2007 - 04/2002
6	ErbB Receptors (EGF Receptor)IBA 01/2023 - 08/2005
6	Trastuzumab (Herceptin)FDA Link 03/2016 - 01/2007
6	Biomarkers (Surrogate Marker)IBA 05/2011 - 06/2002
5	human ERBB2 proteinIBA 01/2023 - 03/2011
5	Paclitaxel (Taxol)FDA LinkGeneric 05/2012 - 04/2002
5	Fluorouracil (Carac)FDA LinkGeneric 07/2007 - 06/2002
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2007 - 06/2002
4	Estrogens (Estrogen)FDA Link 01/2012 - 04/2002
4	iso-sulfan blue (Lymphazurin)FDA LinkGeneric 08/2005 - 01/2003
2	pembrolizumabIBA 01/2024 - 11/2023
2	Opioid Analgesics (Opioids)IBA 03/2020 - 06/2019
2	Phenobarbital (Luminal)FDA Link 03/2017 - 12/2010
2	PlasticsIBA 02/2016 - 05/2002
2	Dihydrotachysterol (AT 10)IBA 01/2016 - 10/2005
2	4-azidobenzylcarazolol (pABC)IBA 01/2010 - 01/2002
2	Monoclonal AntibodiesIBA 01/2007 - 02/2003
2	Coloring Agents (Dyes)IBA 08/2005 - 02/2004
2	Technetium Tc 99m Sulfur Colloid FDA Link 01/2005 - 11/2004
2	Peptides (Polypeptides)IBA 06/2004 - 05/2002
2	VaccinesIBA 08/2003 - 05/2002
1	Protons (Proton)IBA 05/2016
1	Tumor Biomarkers (Tumor Markers)IBA 10/2014
1	Indicators and Reagents (Reagents)IBA 07/2014
1	Biocompatible Materials (Biomaterials)IBA 09/2013
1	Docetaxel (Taxotere)FDA Link 05/2012
1	Carboplatin (JM8)FDA LinkGeneric 05/2012
1	DNA (Deoxyribonucleic Acid)IBA 03/2011
1	taxaneIBA 04/2010
1	Keratins (Keratin)IBA 04/2009

Therapy/Procedure

72	Neoadjuvant Therapy 04/2024 - 01/2002
66	Therapeutics 01/2024 - 02/2002
50	Radiotherapy 04/2024 - 04/2002
46	Mastectomy (Mammectomy) 04/2024 - 01/2002
42	Segmental Mastectomy (Lumpectomy) 01/2022 - 04/2002
38	Drug Therapy (Chemotherapy) 10/2021 - 01/2002
25	Lymph Node Excision (Lymph Node Dissection) 04/2024 - 01/2003
14	Mammaplasty (Breast Reconstruction) 12/2019 - 05/2002
9	Prophylactic Mastectomy 01/2018 - 10/2006
6	Adjuvant Chemotherapy 11/2023 - 07/2002
6	Simple Mastectomy 01/2023 - 03/2004
5	Surgical Instruments (Clip) 01/2019 - 08/2014
4	Aftercare (After-Treatment) 01/2020 - 11/2002
3	Operative Surgical Procedures 10/2016 - 03/2003
3	Catheters 08/2014 - 02/2004
2	Modified Radical Mastectomy (Mastectomy, Modified) 11/2020 - 05/2002
2	Hepatectomy 01/2020 - 05/2012
2	Tissue Expansion Devices (Tissue Expander) 10/2017 - 06/2011
2	Salvage Therapy 10/2013 - 11/2002
2	Adjuvant Radiotherapy 10/2012 - 08/2004
2	Conduction Anesthesia (Regional Anesthesia) 11/2009 - 09/2009
2	Contraindications 04/2007 - 01/2006
2	Chemoprevention 01/2006 - 11/2002
1	Re-Irradiation 01/2020
1	Thoracotomy 03/2015
1	Metastasectomy 05/2012
1	General Anesthesia 11/2009
1	Hysterectomy 08/2007